Radiotherapy of Genito-Urinary Cancer incl. Prostate Cancer – Oncozone publications
February 7, 2008
Below is a non exhaustive list of scientific publications and presentations comprised in oncozone.net on the treatment of genito-urinary cancer including prostate cancer with radiation therapy.
Major title keywords :
acute analysis androgen beam biochemical bladder brachytherapy cancer clinical comparison conformal ct deprivation dose dosimetry evaluation external following guided gy image impact implants improve imrt localized motion outcome patients permanent planning predicts prostate psa quality radiation radiotherapy rectal results risk rtog study survival system therapy toxicity treated treatment volume
To go to the full list of oncozone.net publications per category click here.
To go directly to one of the presentations hereunder, click on the relevant article.
25 years of permanent prostate brachytherapy, how to proceed A Case of Strand Migration After Prostate Seed Implant A Motion Phantom System For Image Quality Assessment of a 64 Slice Volume CT Scanner A Multi-Institutional, Phase I/II Trial of Dose-per-fraction Escalation for Prostate Cancer A New Simulation Technique Using Virtual Reality Visualization to Optomize Beam Geometry in Prostate Cancer IMRT A New Software Tool for Quantitative Verification of IMRT Fluence Maps A Population-Based Assessment of Rectal Cancer Risk Following Radiotherapy for Prostatic Carcinoma A Randomized Cross-Over Study Comparing Two Immobilization Devices For The Treatment Of Prostate Cancer Patients Using Megavoltage CT Scanning To Evaluate Setup Accuracy Accelerated Hypofractionated Radiation Therapy with Neoadjuvant and Concomitant Hormone Therapy for Intermediate Risk Prostate Cancer Accuracy of Automatic Prostate Tracking for Online MRIGRT Accuracy of prostate localization using implanted gold markers and Varian´s On-Board Imager system Achieving a Consensus Definition for Anatomic Boundaries of the CTV (Prostate Bed): Methods and Observer Reproducibility using MRI Adenoviral E2F1 And Antisense MDM2 Sensitize Prostate Cancer Cells To Androgen Deprivation and Radiation Adjuvant versus neo-adjuvant hormonal treatment and radical radiotherapy in early stage and locally advanced prostate cancer African-American Patients with Intermediate-Risk Prostate Cancer Have Improved Biochemical Relapse-Free Survival in a Racially Diverse University Population Antisense MDM2 Oligonucleotides Sensitize Androgen-Insensitive Human Prostate Cancer Cells To Androgen Deprivation In Vitro And In Vivo Antisense MDM2 Sensitizes Prostate Tumors to Radiation Therapy and Androgen Deprivation in vivo Bcl-2 and Bax Predict Prostate Cancer Outcome In Men Treated With Androgen Deprivation And Radiotherapy On RTOG 92-02 Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder CAD-Application in Prostate Cancer – is there an clinical use in defintion of GTV for Dose painting Characterization of Real Time Motion of the Prostate Gland in Patients Receiving External Radiotherapy for Localization Prostate Cancer: Tracking During 1157 Fractions with the Calypso System Clinical feasibility of a new robotic needle insertion method to minimize prostate motion during image guided prostate interventions Clinical Impact of a 3 mm versus 5 mm Action Threshold for Correction of Intrafractional Prostate Motion Identified with Electromagnetic Tracking Clinical Outcomes And Late Toxicities After High Dose Rate Brachytherapy Combined With Hypofractionated External Beam Radiation Therapy For Intermediate-high Risk Prostate Cancer Comparison of a pre planned dose distribution with a real time dose distribution in ultra sound guided 3D conformal brachytherapy of prostate cancer Comparison of prostate targeting for Image Guided Radiation Therapy (IGRT) treatment using a conventional CT interface and SYNGO fusion software Comparison of Radiation Proctitis of Prostate Cancer Treated by 3-Dimensional Conformal Radiotherapy (3D-CRT) Alone and 3D-CRT Plus High Dose Rate Implant Comprehensive I-125 multi-seed analysis comparison for prostate brachytherapy – Dosimetry and visibility analysis Correlation of Planning Scan Anatomy and PSA Relapse in Prone Prostate Cancer Patients Cox-2 Overexpression Predicts Prostate Cancer Outcome: An analysis of RTOG 92-02 Daily Image Guided Radiation Therapy for Prostate Cancer: An assessment of treatment plan reproducibility Development of a nomogram to predict grade 2-3 acute GI toxicity (RTOG EORTC) for prostate cancer 3DCRT Difference in rectal wall dose mapping and reduced late rectal mucosal changes at endoscopic evaluation after radiotherapy with daily endorectal balloon for localised prostate cancer Do Prostate Displacements Between 1.5 and 4.4 mm Need Correction? A Randomized Study Dose escalation in prostate cancer with IMRT (76 Gy- 80 Gy) Acute and late toxicity Dose volume constraints and volume effects for rectal toxicity after external RT for prostate cancer Dosimetric Comparison of IMRT Prostate Cancer Treatment with or without On-line Rotation Correction Dosimetric evaluation of interstitial high-dose-rate implants for localised prostate cancer Dosimetric quality of interstitial high-dose-rate prostate implants The significance of learning curve and improved dose constraints Endorectal Balloons In Prostate Radiotherapy: Difference In Rectal Wall Dose Maps And Reduction Of Late Rectal Mucosa Effects Observed In Rectoscopy Enhanced quality of HDR- interstitial prostate implants due to online-planning procedure Evidence Based Radiation Oncology: Prostate Cancer Expanded Risk Groups Help Determine Which Prostate Radiotherapy Sub-Group May Benefit From Adjuvant Androgen Deprivation Therapy External beam radiotherapy after IOERT for prostate cancer Extracapsular Radiation Dose Annulus Correlates With Biochemical Control in Low-Risk Prostate Brachytherapy Patients: Results of a Prospective Randomized Trial FIRST, the first choice in the management of localised prostate cancer? Greater Than 6 Months of Androgen Deprivation Therapy Does Not Improve Overall Survival for High-risk Prostate Cancer Patients Treated with Radiotherapy or Prostatectomy High Dose Rate (HDR) Monotherapy is Equivalent to Combined HDR Brachytherapy and External Beam Radiation Therapy (EBRT) for Early Prostate Cancer Hypofractionated Stereotactic Radiotherapy for Prostate Cancer: Early Results I-Beam ultrasonography for IMRT treatment of localized prostate carcinoma precision and organ motion Image guided HDR brachytherapy planning – the implication of incorporating biological effects into paradigms based on physical dose Image-Guided Intensity-Modulated Radiation Therapy (IG-IMRT) With Helical Tomotherapy for Prostate Cancer – Importance of Patient Registration For Alignment Image-Guided Radiation Therapy Using an in-room CT – Review of 1762 prostate CT scans Impact of differences in organ contouring and seed localisation by imaging modality on post-implant dosimetry parameters for permanent prostate implants Impact of random position variations on complex dose distributions for prostate IMRT using different margins Impact of rectal preparation with polyethylene glycol (PEG) laxative on pelvic organs geometrical reproducibility Implementation of FEM simulation techniques for organ motion modeling in prostate cancer radiotherapy Implementation of Magnetic Resonance Spectroscopy (MRS) of the prostate into radiotherapy treatment planning Importance of the CT MRI fusion method as a learning tool for CT-based post implant dosimetry in prostate brachytherapy Improvement of Disease Control with Seminal Vesicles Irradiation in Intermediate and High-Risk Patients with Prostate Cancer Improving focal bladder treatment with IMRT Improving the Therapeutic Ratio of Prostate Brachytherapy: Dose Escalation in I-125 Prostate Implants IMRT, what have we learned? A systematic review in prostate cancer Influence Of Patient Selection On Outcome In Prostate Cancer Brachytherapy. The Experience Of The Paris Institut Curie/ Hopital Cochin / Hopital Necker Group On 809 Patients Intensity-modulated radiotherapy (IMRT) as primary therapy for prostate cancer – experience of Ghent University Hospital (GUH) Intra- and interfractional movements of the BeamCath urethral catheter for image-guided radiotherapy of prostate cancer Intra-operative Prostate Brachytherapy – Can EUD assist D90 in assessing intra-operative implant dosimetry and quality Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas Inverse Planning in Prostate Cancer Investigation of EUD- and Dose-Volume Based NTCP Models for Rectal Bleeding, augmented by Principal Component Analysis of DVH Patterns Is D90 A Radiobiologically Sound Endpoint for Evaluation Permanent Seed Prostate Brachytherapy? Late genito-urinary morbidity after 3D conformal radiotherapy for prostate cancer – absence of dose and dose-volume effect Late rectal toxicity after prostate cancer 3DCRT: preliminary results from a prospective multi-centric study (AIROPROS 01-02) Late RTOG-EORTC LENT SOMA and CTCAE graded rectal toxicity in relation to dose distributions in the rectum during radiotherapy for prostate cancer Long term outcomes following Iodine-125 monotherapy for localized prostate cancer Long Term Outcomes Following Iodine-125 Monotherapy For Localized Prostate Cancer: The Results Of A Large European Series Long-term Rectal Function Following Permanent Prostate Brachytherapy Long-time results with a median follow up of 80 months in 3-D conformal radiotherapy of localized prostate cancer at moderate dose Margins for prostate treatment using online position verification, focussing on the magnitude of prostate rotation Matched Pair Analysis Of Patients With Prostate Cancer Treated With IMRT Or 3-D Conformal Radiotherapy Molecular Image Validation utilizing the Correlation of Histopathology and Marker Placement System (CHAMPSSM) Protocol Nadir PSA and time to nadir PSA after radiotherapy with and without androgen deprivation as a predictor of prostate cancer outcome Objective verification of the position of the prostate using implanted markers compared to the use of untrasound repositioning systems On-Line Correction in Prostate Radiotherapy Using the AcculocTM Fiducial Localization System-Is this the Gold Standard in Image Guidance Technology Optimising radiotherapy for seminoma using fields based on surgical templates for retroperitoneal lymph node dissection Optimizing Beam Angles in IMRT – A Comparison Study between Class-solution and Optimized Beam Directions in Prostate Cases Partial Volume Analysis In LDR Brachytherapy Of Prostate Cancer- Comparision Of Intraoperative Ultrasound Planning And Postimplant CT Dosimetry Planning challenges for prostate cancer in the IMRT IGRT era Prediction of the bladder wall location in presence of a varying urinary inflow Predictors for rectal and intestinal acute toxicities from 3DCRT prostate cancer Preoperative PSA Velocity Predicts for Relapse after Prostatectomy Only for Non-Obese (Low BMI) Patients Pretreatment PSA Velocity as a Predictor of Disease Outcome Following Radical Radiation Therapy Prostate Brachytherapy combined with androgen deprivation, is there a rationale Prostate Cancer Distribution in Patients Diagnosed by Transperineal Template-guided Saturation Biopsy Prostate Rotation Measured by Electromagnetic Tracking System: A Multi-Center Analysis Prostate Tumor Biomarker Stability In Archival Tissue From Men Treated With Radiotherapy: An Analysis Of RTOG 92-02 And Fox Chase Randomized Trials Pulse-Dose-Rate (PDR) Brachytherapy as Monotherapy for Localized Prostate Cancer Radiation therapy for localized hormone refractory prostate cancer: Results of Patterns Care Study in Japan Reduction of Prostate Movements During radiotherapy – Results of a randomised study Reimplantation for suboptimal prostate implant. Feasibility study Relapse-Free Survival with Escalating External Beam Radiation Doses in the Treatment of Localized Prostate Cancer: 74 Gy at 2 Gy, 78 Gy at 2 Gy, and Hypofractionated 70 Gy at 2.5 Gy per Fraction Relationship between DVH and rectal acute symptoms during high-dose prostate cancer 3DCRT Second Malignancies After Prostate Brachytherapy: Incidence Of Bladder And Colorectal Cancers In Patients With 15 Years Of Potential Follow-up Serial Ultrasound-Determined Post-Void Residual Urine Volumes During External Beam Radiation Therapy for Clinically Localized Prostate Cancer Should PNI Be Included For Risk-stratification Of Prostate Cancer? Side-effects and efficacy of conformal radiation therapy (CRT) in patients with prostate cancer Socio-demographic Predictors of Biochemical Failure and Survival Among High Risk Patients Treated on Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials: A Meta-analysis Stability of Intraprostatic Electromagnetic Transponders in Patients Receiving Radiation Therapy, With and Without Neoadjuvant and/or Concurrent Androgen Suppression Therapy Statin Use Prior to Radiation Therapy for Prostate Cancer Does Not Improve Outcome: The Fox Chase Experience Step & shoot IMRT for the prostate, more beams, less QA Stereographic targeting in prostate IGRT- speed and precision by daily, automatic positioning correction The Benefit of Intraoperative Image-Guided Adaptative Prostate Brachytherapy : the Hôtel-Dieu of Quebec experience The biological significance of longitudinal changes in PSA – Doubling time during biochemical failure The biological significance of longitudinal changes in PSA; post treatment variations and mistaken biochemical failure The clinical evaluation of inter-fraction time trends in prostate positioning during intensity-modulated radiotherapy The clinical rationale and basis for IGRT in prostate radiotherapy The Effect of Obesity on PSA Recurrence Following External Beam Radiation Therapy for Localized Prostate Cancer The Impact of Body Mass Index on Cause-Specific Biochemical and Overall Survival Following Permanent Prostate Brachytherapy The Impact of Primary Gleason Pattern on Survival Following Brachytherapy for Gleason Score 7 Prostate Cancer The impact of set-up error on quality control of a multi-centric study on rectal toxicity during 3DCRT of prostate cancer AIROPROS01-02 The Influence of a Diet on Prostate Movement and Automatic Prostate Localization on Cone-Beam CT scans for Image Guided Radiotherapy The Influence Of Androgen Suppression Therapy For Prostate Cancer On The Frequency And Timing Of A Fatal Myocardial Infarction The Nadir+2 Definition of Biochemical Failure Predicts for Overall Survival The Post-Treatment PSA Bounce for Prostate Cancer Patients Treated With External Beam RT or Permanent Brachytherapy Alone Is Not Biochemically or Clinically Significant: A Multi-Institutional Pooled Analysis of More Than 7500 Patients The radiobiology of prostate cancer : new thinking from clinical studies The Significance of Organ Motion for Planning Margins in Prostate Radiation Therapy The value of online MRIgRT for prostate deformation Tolerance, Stability and Reliability of Implanted Electromagnetic Transponders in the Prostate: A Multi-Center Analysis Transperineal I-125 Implants for prostate cancer Treatment of intermediate or high risk prostate cancer by dose escalation with HDR brachytherapy: early toxicity and biochemical outcome of two treatment regims Treatment of Prostate Cancer with Photon IMRT and Proton Therapy: a Treatment Planning Comparison Urinary and Bowel Toxicity After External Beam Radiotherapy for Localized Prostate Cancer: Correlation of Acute Versus Late Toxicities Use of dose volume parameters in brachytherapy for prostate and gynaecology
25 years of permanent prostate brachytherapy, how to proceed A Case of Strand Migration After Prostate Seed Implant A Motion Phantom System For Image Quality Assessment of a 64 Slice Volume CT Scanner A Multi-Institutional, Phase I/II Trial of Dose-per-fraction Escalation for Prostate Cancer A New Simulation Technique Using Virtual Reality Visualization to Optomize Beam Geometry in Prostate Cancer IMRT A New Software Tool for Quantitative Verification of IMRT Fluence Maps A Population-Based Assessment of Rectal Cancer Risk Following Radiotherapy for Prostatic Carcinoma A Randomized Cross-Over Study Comparing Two Immobilization Devices For The Treatment Of Prostate Cancer Patients Using Megavoltage CT Scanning To Evaluate Setup Accuracy Accelerated Hypofractionated Radiation Therapy with Neoadjuvant and Concomitant Hormone Therapy for Intermediate Risk Prostate Cancer Accuracy of Automatic Prostate Tracking for Online MRIGRT Accuracy of prostate localization using implanted gold markers and Varian´s On-Board Imager system Achieving a Consensus Definition for Anatomic Boundaries of the CTV (Prostate Bed): Methods and Observer Reproducibility using MRI Adenoviral E2F1 And Antisense MDM2 Sensitize Prostate Cancer Cells To Androgen Deprivation and Radiation Adjuvant versus neo-adjuvant hormonal treatment and radical radiotherapy in early stage and locally advanced prostate cancer African-American Patients with Intermediate-Risk Prostate Cancer Have Improved Biochemical Relapse-Free Survival in a Racially Diverse University Population Antisense MDM2 Oligonucleotides Sensitize Androgen-Insensitive Human Prostate Cancer Cells To Androgen Deprivation In Vitro And In Vivo Antisense MDM2 Sensitizes Prostate Tumors to Radiation Therapy and Androgen Deprivation in vivo Bcl-2 and Bax Predict Prostate Cancer Outcome In Men Treated With Androgen Deprivation And Radiotherapy On RTOG 92-02 Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder CAD-Application in Prostate Cancer – is there an clinical use in defintion of GTV for Dose painting Characterization of Real Time Motion of the Prostate Gland in Patients Receiving External Radiotherapy for Localization Prostate Cancer: Tracking During 1157 Fractions with the Calypso System Clinical feasibility of a new robotic needle insertion method to minimize prostate motion during image guided prostate interventions Clinical Impact of a 3 mm versus 5 mm Action Threshold for Correction of Intrafractional Prostate Motion Identified with Electromagnetic Tracking Clinical Outcomes And Late Toxicities After High Dose Rate Brachytherapy Combined With Hypofractionated External Beam Radiation Therapy For Intermediate-high Risk Prostate Cancer Comparison of a pre planned dose distribution with a real time dose distribution in ultra sound guided 3D conformal brachytherapy of prostate cancer Comparison of prostate targeting for Image Guided Radiation Therapy (IGRT) treatment using a conventional CT interface and SYNGO fusion software Comparison of Radiation Proctitis of Prostate Cancer Treated by 3-Dimensional Conformal Radiotherapy (3D-CRT) Alone and 3D-CRT Plus High Dose Rate Implant Comprehensive I-125 multi-seed analysis comparison for prostate brachytherapy – Dosimetry and visibility analysis Correlation of Planning Scan Anatomy and PSA Relapse in Prone Prostate Cancer Patients Cox-2 Overexpression Predicts Prostate Cancer Outcome: An analysis of RTOG 92-02 Daily Image Guided Radiation Therapy for Prostate Cancer: An assessment of treatment plan reproducibility Development of a nomogram to predict grade 2-3 acute GI toxicity (RTOG EORTC) for prostate cancer 3DCRT Difference in rectal wall dose mapping and reduced late rectal mucosal changes at endoscopic evaluation after radiotherapy with daily endorectal balloon for localised prostate cancer Do Prostate Displacements Between 1.5 and 4.4 mm Need Correction? A Randomized Study Dose escalation in prostate cancer with IMRT (76 Gy- 80 Gy) Acute and late toxicity Dose volume constraints and volume effects for rectal toxicity after external RT for prostate cancer Dosimetric Comparison of IMRT Prostate Cancer Treatment with or without On-line Rotation Correction Dosimetric evaluation of interstitial high-dose-rate implants for localised prostate cancer Dosimetric quality of interstitial high-dose-rate prostate implants The significance of learning curve and improved dose constraints Endorectal Balloons In Prostate Radiotherapy: Difference In Rectal Wall Dose Maps And Reduction Of Late Rectal Mucosa Effects Observed In Rectoscopy Enhanced quality of HDR- interstitial prostate implants due to online-planning procedure Evidence Based Radiation Oncology: Prostate Cancer Expanded Risk Groups Help Determine Which Prostate Radiotherapy Sub-Group May Benefit From Adjuvant Androgen Deprivation Therapy External beam radiotherapy after IOERT for prostate cancer Extracapsular Radiation Dose Annulus Correlates With Biochemical Control in Low-Risk Prostate Brachytherapy Patients: Results of a Prospective Randomized Trial FIRST, the first choice in the management of localised prostate cancer? Greater Than 6 Months of Androgen Deprivation Therapy Does Not Improve Overall Survival for High-risk Prostate Cancer Patients Treated with Radiotherapy or Prostatectomy High Dose Rate (HDR) Monotherapy is Equivalent to Combined HDR Brachytherapy and External Beam Radiation Therapy (EBRT) for Early Prostate Cancer Hypofractionated Stereotactic Radiotherapy for Prostate Cancer: Early Results I-Beam ultrasonography for IMRT treatment of localized prostate carcinoma precision and organ motion Image guided HDR brachytherapy planning – the implication of incorporating biological effects into paradigms based on physical dose Image-Guided Intensity-Modulated Radiation Therapy (IG-IMRT) With Helical Tomotherapy for Prostate Cancer – Importance of Patient Registration For Alignment Image-Guided Radiation Therapy Using an in-room CT – Review of 1762 prostate CT scans Impact of differences in organ contouring and seed localisation by imaging modality on post-implant dosimetry parameters for permanent prostate implants Impact of random position variations on complex dose distributions for prostate IMRT using different margins Impact of rectal preparation with polyethylene glycol (PEG) laxative on pelvic organs geometrical reproducibility Implementation of FEM simulation techniques for organ motion modeling in prostate cancer radiotherapy Implementation of Magnetic Resonance Spectroscopy (MRS) of the prostate into radiotherapy treatment planning Importance of the CT MRI fusion method as a learning tool for CT-based post implant dosimetry in prostate brachytherapy Improvement of Disease Control with Seminal Vesicles Irradiation in Intermediate and High-Risk Patients with Prostate Cancer Improving focal bladder treatment with IMRT Improving the Therapeutic Ratio of Prostate Brachytherapy: Dose Escalation in I-125 Prostate Implants IMRT, what have we learned? A systematic review in prostate cancer Influence Of Patient Selection On Outcome In Prostate Cancer Brachytherapy. The Experience Of The Paris Institut Curie/ Hopital Cochin / Hopital Necker Group On 809 Patients Intensity-modulated radiotherapy (IMRT) as primary therapy for prostate cancer – experience of Ghent University Hospital (GUH) Intra- and interfractional movements of the BeamCath urethral catheter for image-guided radiotherapy of prostate cancer Intra-operative Prostate Brachytherapy – Can EUD assist D90 in assessing intra-operative implant dosimetry and quality Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas Inverse Planning in Prostate Cancer Investigation of EUD- and Dose-Volume Based NTCP Models for Rectal Bleeding, augmented by Principal Component Analysis of DVH Patterns Is D90 A Radiobiologically Sound Endpoint for Evaluation Permanent Seed Prostate Brachytherapy? Late genito-urinary morbidity after 3D conformal radiotherapy for prostate cancer – absence of dose and dose-volume effect Late rectal toxicity after prostate cancer 3DCRT: preliminary results from a prospective multi-centric study (AIROPROS 01-02) Late RTOG-EORTC LENT SOMA and CTCAE graded rectal toxicity in relation to dose distributions in the rectum during radiotherapy for prostate cancer Long term outcomes following Iodine-125 monotherapy for localized prostate cancer Long Term Outcomes Following Iodine-125 Monotherapy For Localized Prostate Cancer: The Results Of A Large European Series Long-term Rectal Function Following Permanent Prostate Brachytherapy Long-time results with a median follow up of 80 months in 3-D conformal radiotherapy of localized prostate cancer at moderate dose Margins for prostate treatment using online position verification, focussing on the magnitude of prostate rotation Matched Pair Analysis Of Patients With Prostate Cancer Treated With IMRT Or 3-D Conformal Radiotherapy Molecular Image Validation utilizing the Correlation of Histopathology and Marker Placement System (CHAMPSSM) Protocol Nadir PSA and time to nadir PSA after radiotherapy with and without androgen deprivation as a predictor of prostate cancer outcome Objective verification of the position of the prostate using implanted markers compared to the use of untrasound repositioning systems On-Line Correction in Prostate Radiotherapy Using the AcculocTM Fiducial Localization System-Is this the Gold Standard in Image Guidance Technology Optimising radiotherapy for seminoma using fields based on surgical templates for retroperitoneal lymph node dissection Optimizing Beam Angles in IMRT – A Comparison Study between Class-solution and Optimized Beam Directions in Prostate Cases Partial Volume Analysis In LDR Brachytherapy Of Prostate Cancer- Comparision Of Intraoperative Ultrasound Planning And Postimplant CT Dosimetry Planning challenges for prostate cancer in the IMRT IGRT era Prediction of the bladder wall location in presence of a varying urinary inflow Predictors for rectal and intestinal acute toxicities from 3DCRT prostate cancer Preoperative PSA Velocity Predicts for Relapse after Prostatectomy Only for Non-Obese (Low BMI) Patients Pretreatment PSA Velocity as a Predictor of Disease Outcome Following Radical Radiation Therapy Prostate Brachytherapy combined with androgen deprivation, is there a rationale Prostate Cancer Distribution in Patients Diagnosed by Transperineal Template-guided Saturation Biopsy Prostate Rotation Measured by Electromagnetic Tracking System: A Multi-Center Analysis Prostate Tumor Biomarker Stability In Archival Tissue From Men Treated With Radiotherapy: An Analysis Of RTOG 92-02 And Fox Chase Randomized Trials Pulse-Dose-Rate (PDR) Brachytherapy as Monotherapy for Localized Prostate Cancer Radiation therapy for localized hormone refractory prostate cancer: Results of Patterns Care Study in Japan Reduction of Prostate Movements During radiotherapy – Results of a randomised study Reimplantation for suboptimal prostate implant. Feasibility study Relapse-Free Survival with Escalating External Beam Radiation Doses in the Treatment of Localized Prostate Cancer: 74 Gy at 2 Gy, 78 Gy at 2 Gy, and Hypofractionated 70 Gy at 2.5 Gy per Fraction Relationship between DVH and rectal acute symptoms during high-dose prostate cancer 3DCRT Second Malignancies After Prostate Brachytherapy: Incidence Of Bladder And Colorectal Cancers In Patients With 15 Years Of Potential Follow-up Serial Ultrasound-Determined Post-Void Residual Urine Volumes During External Beam Radiation Therapy for Clinically Localized Prostate Cancer Should PNI Be Included For Risk-stratification Of Prostate Cancer? Side-effects and efficacy of conformal radiation therapy (CRT) in patients with prostate cancer Socio-demographic Predictors of Biochemical Failure and Survival Among High Risk Patients Treated on Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials: A Meta-analysis Stability of Intraprostatic Electromagnetic Transponders in Patients Receiving Radiation Therapy, With and Without Neoadjuvant and/or Concurrent Androgen Suppression Therapy Statin Use Prior to Radiation Therapy for Prostate Cancer Does Not Improve Outcome: The Fox Chase Experience Step & shoot IMRT for the prostate, more beams, less QA Stereographic targeting in prostate IGRT- speed and precision by daily, automatic positioning correction The Benefit of Intraoperative Image-Guided Adaptative Prostate Brachytherapy : the Hôtel-Dieu of Quebec experience The biological significance of longitudinal changes in PSA – Doubling time during biochemical failure The biological significance of longitudinal changes in PSA; post treatment variations and mistaken biochemical failure The clinical evaluation of inter-fraction time trends in prostate positioning during intensity-modulated radiotherapy The clinical rationale and basis for IGRT in prostate radiotherapy The Effect of Obesity on PSA Recurrence Following External Beam Radiation Therapy for Localized Prostate Cancer The Impact of Body Mass Index on Cause-Specific Biochemical and Overall Survival Following Permanent Prostate Brachytherapy The Impact of Primary Gleason Pattern on Survival Following Brachytherapy for Gleason Score 7 Prostate Cancer The impact of set-up error on quality control of a multi-centric study on rectal toxicity during 3DCRT of prostate cancer AIROPROS01-02 The Influence of a Diet on Prostate Movement and Automatic Prostate Localization on Cone-Beam CT scans for Image Guided Radiotherapy The Influence Of Androgen Suppression Therapy For Prostate Cancer On The Frequency And Timing Of A Fatal Myocardial Infarction The Nadir+2 Definition of Biochemical Failure Predicts for Overall Survival The Post-Treatment PSA Bounce for Prostate Cancer Patients Treated With External Beam RT or Permanent Brachytherapy Alone Is Not Biochemically or Clinically Significant: A Multi-Institutional Pooled Analysis of More Than 7500 Patients The radiobiology of prostate cancer : new thinking from clinical studies The Significance of Organ Motion for Planning Margins in Prostate Radiation Therapy The value of online MRIgRT for prostate deformation Tolerance, Stability and Reliability of Implanted Electromagnetic Transponders in the Prostate: A Multi-Center Analysis Transperineal I-125 Implants for prostate cancer Treatment of intermediate or high risk prostate cancer by dose escalation with HDR brachytherapy: early toxicity and biochemical outcome of two treatment regims Treatment of Prostate Cancer with Photon IMRT and Proton Therapy: a Treatment Planning Comparison Urinary and Bowel Toxicity After External Beam Radiotherapy for Localized Prostate Cancer: Correlation of Acute Versus Late Toxicities Use of dose volume parameters in brachytherapy for prostate and gynaecology
acceletronics, AIO, aquaplast, bayer, bayer healthcare, Biolucent, bogardus, bogardus medical sytems, Brachysciences, BrainLab, bristol meyers squibb, calypso, calypso medical, cancer, cancer treatment, carestream, carestream health, Cianna, Civco, civco medical solutions, congress, core, core oncology, cytogen, decimal, diacor, efficast, Elekta, fluke, gammex, gastro intestinal cancer, GE healthcare, gemstar, genentech, genital cancer, hologic, IBA, IBA proton therapy, IBT, integra, integra radionics, intraop, intraop medical corporation, isodose control, isoray, isoray medical, k&s, LAP, medtec, mick, NMPE, north american scientific, oncology, oncozone, Optivus, Orfit, orfit industries, oxyx, pfizer, pfizer oncology, philips, philips medical systems, posicast, poster, presentation, prostate, prostate cancer, prowess, publication, qfix, radiation oncology, radiation products design, radiotherapy, research, resonant, resonant medical, roche, roche imclone, roche imclone systems, sanofi, sanofi aventis, sicel, sicel technologies, Siemens, siemens medical solutions, Sinmed, Standard Imaging, Still River Systems, theragenics, tomotherapy, urinary tract cancer, vantage, vantage oncology, Varian, varian medical systems, vidar, vision rt, WFR, wfr aquaplast, xoft
